Barcelona May 11 and 12 , 2018

II Cannabmed

BRIDGING THE GAP BETWEEN MEDICAL CANNABIS AND PATIENTS

CAT | ESP | ENG

The CANNABMED Congress is the only event in Spain dedicated to education and dialogue on medicinal cannabis. In this second edition, patients will be centre stage and the event will also have special interest for health professionals.

CANNABMED 2018 will enrich the conversation about the regulation of medicinal cannabis and give visibility to the concerns and demands of the affected group.

WHY CANNABMED

At the policy-level, we are at a critical juncture after 17 years of waiting for the Parliament of Catalonia to act on a declaration made on April 25, 2001. At that time the Parliament of Catalonia approved a non-legal proposal signed by all parliamentary groups, which called for the Executive Board "to take the necessary steps to authorize the therapeutic use of the cannabis." This lack of action has had significant impacts on people who use medical cannabis, who face stigma and are suffering from this neglect from the state.

The CANNABMED Congress seeks to offer training – based on the best available evidence – to health care professionals that will bridge the gap between patients, activists, scientists, media, and policy-makers. Together we will take a step towards a brighter future where the full potential of medical cannabis can be realized.

Friday 11

-

Barcelona’s College of Physicians (COMB)

-

Aimed exclusively at health professionals (medical colleges and nursing can receive training credits)


9:00h

Doors open and accreditations

9:30h

Conference welcome and opening

Joan Colom (Health Department Catalonia), Queralt Prat (UPRC), Òscar Parés (ICEERS)

10 a 10.40h Master Class (Videoconferencing)

"The history of cannabinoid-based medicine: From pre-history to modern cannabinoid-based drugs"

Ethan Russo

Ethan Russo

Ethan Russo, MD, is a board-certified neurologist, psychopharmacology researcher, and Director of Research and Development for the International Cannabis and Cannabinoids Institute. Previously he was Medical Director of PHYTECS, 2015-2017, and from 2003-2014, he was Senior Medical Advisor, medical monitor/study physician to GW Pharmaceuticals for numerous Phase I-III clinical trials of Sativex® and Epidiolex®. He graduated from the University of Pennsylvania, and the University of Massachusetts Medical School. He is a former president of the International Cannabinoid Research Society and former Chairman of the International Association for Cannabinoid Medicines, and author/editor of seven books on cannabis and medicinal herbs

10:40 a 11:30h Master Class

“From the endocannabinoid system to the endocannabinoidome”

José Carlos Bouso

José Carlos Bouso

José Carlos Bouso holds a degree in Psychology from the Universidad Autónoma de Madrid (UAM) and a PhD in Pharmacology from the Autonomous University of Barcelona (UAB). He has developed his scientific activity at the UAM, at the Institute of Biomedical Research - IIB Sant Pau and at the Hospital del Mar Institute of Medical Research (IMIM). He has carried out neuroimaging and neuropsychological research on the long-term effects of cannabis use. Actualmemte is the Director of Scientific Projects of the ICEERS Foundation, where he develops studies on the state of health and the quality of life of people with chronic diseases that use cannabis for self-medication purposes. He is co-author of the book: "Marihuana as medicine?", which served as a working document and political incidence in the legalization of medicinal cannabis in the Senate of Mexico.

11:30 - 12:00h, Break

12:00- 12:30h Master Class

"How to evaluate the quality of medicinal cannabis

Arno Hazekamp

Arno Hazekamp

Independent consultant for cannabis R&D projects, Former Head of Research & Education at Bedrocan International. Dr. Hazekamp studied at Leiden University, the Netherlands, where he worked for over 10 years in the School of Biology (Bachelor’s) and the School of Pharmaceutical Sciences (Master’s), under the celebrated prof. Rob Verpoorte (1994-2000). He graduated with honors (2001). As a plant biochemist, he continued with the first PhD study on the medicinal properties of the cannabis plant in The Netherlands (2001-2007). Arno worked closely with the only legal cannabis grower in Europe (Bedrocan) on projects covering quality control, product development and basic research. He actively participated in the medicinal cannabis program of the Dutch Health Ministry, and was a strong advocate of a more science-based approach on the medicinal use of cannabis. .

12:30- 14:15h Round table

"The endocannabinoid system and its therapeutic modulation"

Javier Fernández Ruiz, Timna Naftali , Kirsten Mueller-Vahl, Sandra Blasco Benito, Rocio Girón Moreno Chaired by: Michael Collins (Drug Policy Alliance)

Javier Fernández Ruiz

Javier Fernández Ruiz is a Doctor of Biological Sciences from the Complutense University (1986). He is currently a Professor in the Department of Biochemistry and Molecular Biology of the Faculty of Medicine of the Universidad Complutense. Together with his teaching activity at the university in subjects of the Neurochemistry and Neurobiology area, both in Bachelor / Grado and Master's, he has been devoting 36 years to research in different diseases of the Central Nervous System, having been the author of 231 articles of research and 42 articles of revision in international magazines. Also 41 chapters in books and 5 patents. He has lectured at universities and national or foreign research centers, as well as numerous presentations at national and international conferences. He is currently the Principal Investigator of the CANNABINOIDES-BBM3 research group of the Complutense University, and also Principal Investigator of the University Institute for Research in Neurochemistry, CIBERNED and IRYCIS.

Timna Naftali

I was involved with studies in IBD from the beginning of my residency, when I initiated and conducted a study on the treatment of ulcerative colitis with cyclosporine. I was involved is several studies in the following years but lately I have become interested in the question of the role of cannabinoids in IBD. I was intrigued into the subject by several patients of mine in whom I saw a significant improvement after commencing consumption of cannabis. I realized then that no controlled study was ever conducted in human IBD. In the following years I have conducted several studies investigating use of cannabis by IBD patients including the first placebo controlled trial of cannabis in Crohns disease and another study of cannabis in ulcerative colitis (to be presented in the coming ECCO conference in February 2018).My presentation of the summery of my work in the annual conference of the Israeli gastroenterology association won the prize of the best presentation of the conference

Kirsten Mueller-Vahl

Dr. Kirsten Müller-Vahl, M.D., is a Professor of Psychiatry at the Department of Psychiatry, Socialpsychiatry and Psychotherapy at the Hannover Medical School (MHH), Germany. She is a specialist in both neurology and adult psychiatry and an expert for Tourette Syndrome. Since 1998 she is a member and 2. Chairwoman of the national German Association for Cannabinoid Medicines (ACM). She is a founding member (2000) of the International Association for Cannabinoid Medicines (IACM), has been the 1. Chairwoman of the IACM (2007-2009) and is presently the Vice President of the IACM (since 2015). At the 9th IACM Conference on Cannabinoids in Medicine 2017 she received the IACM Award 2017 for Clinical Research for her special achievements regarding the re-introduction of cannabis and cannabinoids as medicine.

Sandra Blasco Benito

Sandra Blasco (Madrid, 1988) holds a degree in Biology from the Complutense University of Madrid in 2012 and completed the Master's in Biochemistry, Molecular Biology and Biomedicine in 2013. Her scientific career began during the degree when she joined the group of Dr. Cristina Sánchez and Dr. Manuel Guzmán. In 2014, she began her PhD in the same research group with the objective of studying the anti-tumor effect of cannabinoids in breast cancer. During these years of doctorate she has taken stays in other research centers in Spain (University of Barcelona) and abroad (Monash University, Australia).

Rocio Girón Moreno

Mª del Rocío Girón Moreno. Universidad Rey Juan Carlos. Deputy Professor Doctor. Degree in Pharmacy, Doctor of Pharmacy, Specialist in Pharmacology and in Food and Nutrition Applied. Scholarships: Scholarship CSIC 1998. Lines of Investigation of Interest for the Industrial Sector; Grant of the Framework Agreement between Laboratories Dr. Esteve, S.A. and the Complutense University of Madrid; Postdoctoral scholarship from the Japanese Government (Monbukagakusho); Scholarship of the Spanish Society of Pain 2017 for support to research projects. 2 six-year research, participation in 17 research projects (9 related to cannabinoid research), 12 research contracts, 19 publications indexed in magazines of renowned scientific prestige; 4 patents, 62 communications to congresses. Direction of 3 DEAS and 1 Doctoral Thesis (awarded by the Spanish Society of Pain), 2 Master Finals and 19 End of Degree Projects.

Lunch, 14.15 a 15.45h

15:45- 17:30h Rpund table

CBD and other therapeutic action cannabinoids"

Hari Bhathal, Celia Morgan, José Carlos Bouso, Stefan Martin Meyer Chaired by: Guillermo Bagaría (COFB)

Hari Bhathal

Dr. Hari Bhathal. Director of Neurocenter Barcelona, at the Teknon Medical Center Graduate in Medicine and Surgery at the Universidad Autónoma de Madrid and specialist via MIR of Neurology at the San Carlos Clinic Hospital in Madrid. I completed my Epilepsy Fellowship at the Montréal Neurological Institute and I have practiced as an epileptologist at the Epilepsy Units of the Hospital Clínico de Madrid, at the Infant Leonor Hospital and currently in the Epilepsy Unit of the Teknon Medical Center. He has also been Principal Investigator in more than 10 clinical trials of phases 2 and 3 in epilepsy.

Celia Morgan

I am interested in the effects of drugs and alcohol on the brain and behavior. My research has focused on examining the positive and negative effects of recreational drugs on cognition. Through behavioral and neuroimaging studies, I have investigated the chronic effects of relatively new substances such as ketamine, MDMA and mephedrone. My work has also focused on what makes people vulnerable to the harmful effects of certain substances, such as cannabis. More recently, I have started to investigate the potentially therapeutic sides of controlled substances in clinical trials aimed at the treatment of addiction. I completed my degree and my Ph.D. in UCL, I spent some time at Yale University in a scholarship program, before returning to UCL for a post-doc. After that, I worked at the University of Melbourne as a visiting researcher and returned to UCL to obtain a scholarship and then a chair. I joined the University of Exeter as main professor in May 2013. I currently have an honorary post at University College London.

José Carlos Bouso

José Carlos Bouso holds a degree in Psychology from the Universidad Autónoma de Madrid (UAM) and a PhD in Pharmacology from the Autonomous University of Barcelona (UAB). He has developed his scientific activity at the UAM, at the Institute of Biomedical Research - IIB Sant Pau and at the Hospital del Mar Institute of Medical Research (IMIM). He has carried out neuroimaging and neuropsychological research on the long-term effects of cannabis use. Actualmemte is the Director of Scientific Projects of the ICEERS Foundation, where he develops studies on the state of health and the quality of life of people with chronic diseases that use cannabis for self-medication purposes. He is co-author of the book: "Marihuana as medicine?", which served as a working document and political incidence in the legalization of medicinal cannabis in the Senate of Mexico.

Stephen Meyer

MBA, is Founder and Director of Phytoplant Research S.L. and member of the Board of Directors of Vivacell Biotechnology España S.L., two companies dedicated to the investigation of fitocannabinoides in Córdoba, Spain. Stefan has a decade of experience in the development of products rich in Cannabis / cannabinoids for the pharmaceutical, nutraceutical and dermocosmetic sectors.

17:30 a 18:00h Break

18:00 a 19:30h Round table

"The difficulties, opportunities and challenges of advising people who consume cannabis and derivatives for health reasons in Spain"

Mariano Garcia de Palau, Albert Estrada, Mariano Baffi, Fernando Caudevilla Chaired by: Joan Comorera (Senator EnComú)

Mariano Garcia de Palau

Born in Barcelona on February 17, 1956. He graduated in Medicine and Surgery at the University of Barcelona in 1979. During 38 years he works as an emergency doctor in the field of occupational medicine. His interest in cannabis arises accidentally, and for about 15 years he has been studying the therapeutic use of cannabis. He currently works in Kalapa Clinic, where he advises on treatments with cannabinoids, carries out clinical work with patients and collaborates with different entities and associations such as Catfac. He is a member of the Observatorio Español Cannabis Medicinal. Regular member of IACM..

Albert Estrada

Degree in medicine from the Autonomous University of Barcelona and specialist via MIR in Clinical Biochemistry. He is a member, among others, of the Spanish Society of Clinical Chemistry, the Catalan Association of Sciences of the Clinical Laboratory and the Spanish Society of Research on Cannabinoids. He works as a cannabis adviser in the reduction of risks and attention to therapeutic users in the field of cannabis associations and teaches conferences on prevention and reduction of risks in the use of cannabis.

Mariano Baffi

Palliative physician, I work in the public health service as part of an interdisciplinary team of home care and palliative care. It collaborates with an association of cannabis users in Barcelona, advising treatments with a focus mainly on pain of difficult control. Co-author of various publications in the field of palliative care, I participate in research and training projects for public health professionals on strategies for controlling symptoms, care and palliative care, having also carried out teaching activities at scientific conferences.

Fernando Caudevilla

Family Physician. Expert in University Expert Medicine in Drug Dependencies. Medical Consultant of the Energy Control NGO. He combines his welfare activity as a Family Physician in the Public Health Service with different research, outreach, training and direct attention to patients in new drugs, cryptomercats and therapeutic cannabis among other fields. Co-author of more than 15 scientific articles on drugs.

-

Accredited by the Catalan Board of Continuing Education of the Health Professions - Commission of Continuing Education of the National System of Health

0,9 Credits

Register Number 09/021741-MD


-

-

Saturday 12

-

Center of Contemporary Culture of Barcelona (Hall CCCB), Barcelona

-

A day for patients, activists, relatives, caregivers, health professionals, and allies. –


-

9.30 a 10h

Welcome and opening

Queralt Prat (UPRC), Òscar Parés (ICEERS)

10 a 10.45h

International Perspective

Manu Sareen (former Minister of Dinamarca), Jose Carlos Bouso (ICEERS), Kenzi Riobulet (FAAAT think & do tank) - Chaired by: Iria Caride (UPRC)

10:45 a 11:15h

Quality control for cannabis-based products

Ivan Fornís (Energy Control), Jorge Hermes (MiniVap) - Chaired by: Noelia Illera (UPRC)

11:15 a 11:45h Break

11:45 a 13

Chronic pain and quality of life

Albert Estrada (Physician), Daniel Jimenez (ICEERS), Alejandra Outomuro (médico), Claudia Zangolini (UPRC) Chaired by: Ben de Loenen (ICEERS)

13 a 14h

The voices of people affected by prohibition

Aura Roig (Metzineres), Raul Jimenez (Social Educator), Noemí Sanchez (REMA Representative). Chaired by: Antoni Llort (ARSU)

14 a 15.30h Lunch

15:30 a 16:30

Cannabis in cancer and palliative care

Mariano Baffi (Physician), Sandra Blasco (researcher), Janosch Kratz (Physician Kalapa Clinic), Jesús (pacient)

16:30 a 17:30h

The potential of cannabinoid treatment in other chronic diseases

Josep Pàmies (Farmer-Activist)Alberto Sainz (GHMedical), Bryan Peguero (Physician Kalapa Clinic), Anna Campos (pacient representative)

17:30 a 18:30h

The use of cannabinoids in the treatment of epilepsy

Mariano García de Palau (Physician Kalapa Clinic), Santi Martinez (UPRC), Carme Bonafont (UPRC) Hari Bhathal (Director Neurocenter Barcelona), Raquel (mother of patient)

18:30 a 19:00h Break

19:00 a 19:30h

Political party representative’s panel

Marta Ribas (Cat En Comú), Raúl Moreno (PSC), Gemma Espigares (ERC), Noemi de la Calle (Ciutadans), Josep Riera (JuntsXCat). Chaired by: David P. Martínez (UdPdD)

19:40 a 20h

Conclusions

Queralt Prat (UPRC), Michael Collins (DPA), José Carlos Bouso (ICEERS)

Contact

Cristina Sánchez
cristinasanchez@iceers.org
CANNABMED
NGO_ICEERS

ICEERS is an international non-profit working to shape a future where psychoactive plant practices are valued and integrated parts of society.

Collaborate:
Main Sponsors:
Sponsors:
Promote: